Drug factory · FDA FEI 3004229375
Shandong Anxin Pharmaceutical Co., Ltd.
No. 849, Dongjia Town, Licheng Dist., Jinan, China
Problems found, fixed voluntarily at FDA's last inspection, Jul 16, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
6 drug inspections on record since 2010: 1 with no problems, 5 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Piperacillin and Tazobactam | Makes it, makes the active ingredient, tests it, packages it and labels it | Apotex Corp., BluePoint Laboratories., Sandoz Inc., Shandong Anxin Pharmaceutical Co., Ltd. | 60505-6156, 60505-6157, 60505-6159 +10 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jul 16, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 18, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 1, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 2, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 27, 2013 | No problems found | Drug Quality Assurance | — |
| Jun 25, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture; label; manufacture; pack.